Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01331564 · ClinicalTrials.gov registry record · Phase 3

eMOMS of Rochester

A Phase 3 study of Gestational Weight Gain and Postpartum Weight Retention, sponsored by University of Rochester.

Completed
Registry status
Phase 3
Development phase
1,641
Enrollment target
1
Study location

NCT01331564 is a Phase 3 study of Gestational Weight Gain and Postpartum Weight Retention that has completed, run by University of Rochester. The registered enrollment target is 1,641 participants, above the 259-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (534% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01331564, a Phase 3 study of Gestational Weight Gain and Postpartum Weight Retention, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
Phase 3
Development phase
1,641 participants
Enrollment target
1
Study location

Study Summary

The project aims to develop, implement and evaluate electronically-mediated behavioral intervention programs for pregnant and postpartum women in order to prevent excessive weight gain during pregnancy and postpartum weight retention.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL electronic intervention during pregnancy and postpartum
  • BEHAVIORAL electronic intervention during pregnancy

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 1,641 participants
Start Date 2011-05
Est. Completion 2014-12
Phase Phase 3

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT01331564

The ClinicalTrials.gov registry entry for NCT01331564 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,641 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 259-participant average among 7 other Gestational Weight Gain trials with a reported enrollment target (534% higher). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gestational Weight Gain appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT01331564 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01331564 about?

NCT01331564 is a clinical study titled "eMOMS of Rochester". The project aims to develop, implement and evaluate electronically-mediated behavioral intervention programs for pregnant and postpartum women in order to prevent excessive weight gain during pregnancy and postpartum weight retention.

What is the current status of trial NCT01331564?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,641 participants. The study started on 2011-05. Estimated completion is 2014-12.

What conditions does trial NCT01331564 study?

This clinical trial studies the following conditions: Gestational Weight Gain, Postpartum Weight Retention.

What interventions are being tested in trial NCT01331564?

The interventions under investigation include: Control (BEHAVIORAL), electronic intervention during pregnancy and postpartum (BEHAVIORAL), electronic intervention during pregnancy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01331564?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01331564 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Weight Gain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.